Welcome to CDC Stacks | Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012 - 35535 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012
Filetype[PDF - 1.05 MB]


Details:
No Related Documents.
You May Also Like:
  1. Neisseria meningitidis Serogroup W, Burkina Faso, 2012
    Personal Author:
    MacNeil, Jessica R.; Medah, Isaïe; Koussoubé, Daouda; Novak, Ryan T.; Cohn, Amanda C.; Diomandé, Fabien V.K.; Yelbeogo, Denis; Kambou, Jean Ludovic; Tarbangdo, Tiga F.; Ouédraogo-Traoré, Rasmata; Sangaré, Lassana; Hatcher, Cynthia; Vuong, Jeni; Mayer, Leonard W.; Djingarey, Mamoudou H.; Clark, Thomas A.; Messonnier, Nancy E.;
    Published:
    Mar 2014
    Source:
    Emerg Infect Dis. 20(3):394-399.
    Description:
    Multidrug- (MDR) and extensively drug-resistant tuberculosis (XDR TB) are commonly associated with Beijing strains. However, in KwaZulu-Natal, South Africa, which has among the highest incidence and mortality for MDR and XDR TB, data suggest that non...
    File Type:
    Filetype[PDF - 576.47 KB]
  2. Neisseria meningitidis Serogroup W, Burkina Faso, 2012
    Personal Author:
    MacNeil, Jessica R.; Medah, Isaïe; Koussoubé, Daouda; Novak, Ryan T.; Cohn, Amanda C.; Diomandé, Fabien V.K.; Yelbeogo, Denis; Kambou, Jean Ludovic; Tarbangdo, Tiga F.; Ouédraogo-Traoré, Rasmata; Sangaré, Lassana; Hatcher, Cynthia; Vuong, Jeni; Mayer, Leonard W.; Djingarey, Mamoudou H.; Clark, Thomas A.; Messonnier, Nancy E.;
    Published:
    Mar 2014
    Source:
    Emerg Infect Dis. 20(3):394-399.
    Description:
    In 2010, Burkina Faso became the first country to introduce meningococcal serogroup A conjugate vaccine (PsA-TT). During 2012, Burkina Faso reported increases in Neisseria meningitidis serogroup W, raising questions about whether these cases were a n...
    File Type:
    Filetype[PDF - 576.47 KB]
  3. Meningitis Serogroup W135 Outbreak, Burkina Faso, 2002
    Personal Author:
    Nathan, Nicolas; Rose, Angela M.C.; Legros, Dominique; Tiendrebeogo, Sylvestre R.M.; Bachy, Catherine; Bjørløw, Egil; Firmenich, Peter; Guerin, Philippe J.; Caugant, Dominique A.;
    Published:
    Jun 2007
    Source:
    Emerg Infect Dis. 13(6):920-923.
    Description:
    In 2002, the largest epidemic of Neisseria meningitidis serogroup W135 occurred in Burkina Faso. The highest attack rate was in children <5 years of age. We describe cases from 1 district and evaluate the performance of the Pastorex test, which had g...
    File Type:
    Filetype[PDF - 336.28 KB]
  4. The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012
    Personal Author:
    Retchless, Adam C.; Hu, Fang; Ouédraogo, Abdoul-Salam; Diarra, Seydou; Knipe, Kristen; Sheth, Mili; Rowe, Lori A.; Sangaré, Lassana; Ky Ba, Absetou; Ouangraoua, Soumeya; Batra, Dhwani; Novak, Ryan T.; Ouédraogo Traoré, Rasmata; Wang, Xin;
    Published:
    2016 Nov-Dec
    Source:
    mSphere. 2016; 1(6).
    Description:
    Epidemics of invasive meningococcal disease (IMD) caused by meningococcal serogroup A have been eliminated from the sub-Saharan African so-called "meningitis belt" by the meningococcal A conjugate vaccine (MACV), and yet, other serogroups continue to...
    File Type:
    Filetype[PDF - 410.71 KB]
  5. Modeling the Cost-Effectiveness of the Integrated Disease Surveillance and Response (IDSR) System: Meningitis in Burkina Faso
    Personal Author:
    Somda, Zana C.; Perry, Helen N.; Messonnier, Nancy R.; Djingarey, Mamadou H.; Ki, Salimata Ouedraogo; Meltzer, Martin I.;
    Published:
    Sep 28 2010
    Source:
    PLoS One. 5(9).
    Description:
    Background : Effective surveillance for infectious diseases is an essential component of public health. There are few studies estimating the cost-effectiveness of starting or improving disease surveillance. We present a cost-effectiveness analysis th...
    File Type:
    Filetype[PDF - 768.83 KB]